Smart scan
Point it at a matter: it detects document types, builds the chronology, and lists every party. Live.
Smart scan / 1029-00001
Thornwick Medical Research Institute, Inc
Finance & Banking
Document types detected
Contract / agreement7
Analysis / memo2
Correspondence2
Engagement letter1
Parties across the matter
All SACaldwell LLPDATA MANAGEMENT AND SADunkin' Donuts IncHARKNESS LLPHarborline Partners LLCHarkness LLPKey IncM. CastañedaThe SA
Chronology
2027-12-31 · closing-checklist.xlsx
… occurrence / $25,000,000 aggregate; Policy period: January 1, 2026 – December 31, 2027; Request letter sent by C&H 7 | Insurance | Certificate of Insurance from Pinnacle Mutual …
2027-06-30 · memo-ip-publication-rights-analysis.docx
… first patient enrollment: April 7, 2026 • Estimated last enrollment: June 30, 2027 • Estimated study completion: June 30, 2029 • IDE supplement filing target: March 15, 2 …
2027-06-30 · closing-checklist.xlsx
… pcoming April 7, 2026 | Estimated first patient enrollment | Upcoming June 30, 2027 | Estimated last patient enrollment | Upcoming June 30, 2029 | Estimated study completion …
2027-06-30 · clinical-trial-agreement-execution.docx
… t is April 7, 2026. The estimated date for last patient enrollment is June 30, 2027. The estimated date for Study completion (last patient, last visit) is June 30, 2029. Ins …
2027-06-30 · exhibit-a-study-budget.xlsx
… × $38,000 each Last Patient Enrollment (Subject 45 — Installment 1) | June 30, 2027 | Per-Subject Payment (Enrollment) | Included above | $2,247,500.00 | Estimated last pati …
2027-04-07 · exhibit-a-study-budget.xlsx
… | $237,500.00 | Payable within 30 days of period start date Year 2 | April 7, 2027 | April 6, 2028 | $237,500.00 | Payable within 30 days of period start date Year 3 | Apri …
2027-04-06 · exhibit-a-study-budget.xlsx
… od End Date | Annual Amount | Payment Timing Year 1 | April 7, 2026 | April 6, 2027 | $237,500.00 | Payable within 30 days of period start date Year 2 | April 7, 2027 | Apri …
2026-04-07 · memo-indemnification-analysis.docx
… sed on current projections, first patient enrollment is estimated for April 7, 2026, with estimated study completion on June 30, 2029. The designated Principal Investigator …
2026-04-07 · memo-ip-publication-rights-analysis.docx
… otocol No. HUMC-IRB-2025-0847) • Estimated first patient enrollment: April 7, 2026 • Estimated last enrollment: June 30, 2027 • Estimated study completion: June 30, 2029 …
2026-04-07 · closing-checklist.xlsx
… alization and DSMB readiness required prior to first enrollment (est. April 7, 2026) STATUS SUMMARY Complete | 3 In Progress | 7 Pending | 4 N/A | 0 Total Items | 14 [sheet: …
2026-04-07 · email-indemnification-negotiation-update.eml
… 2026** (IDE G260012), and the estimated first patient enrollment of **April 7, 2026**. --- I am available to discuss any of the above by phone tomorrow morning if that wou …
2026-04-07 · email-internal-signing-status-update.eml
… it stays on TMRI's radar. Estimated first patient enrollment remains April 7, 2026. That timeline is tight, so the IDE supplement needs priority attention this week and nex …
2026-04-07 · email-ip-publication-negotiation-update.eml
… ch 15, 2026, and to support the estimated first patient enrollment of April 7, 2026. - **Client Authorization:** I would ask that you each review this summary and **confirm …
2026-04-07 · transmittal-letter-execution-version.docx
… ry timeline, including the estimated first patient enrollment date of April 7, 2026, which date is itself dependent upon timely FDA review and acceptance of the IDE suppleme …
2026-04-07 · clinical-trial-agreement-execution.docx
… e index procedure. The estimated date for first patient enrollment is April 7, 2026. The estimated date for last patient enrollment is June 30, 2027. The estimated date for …
2026-04-07 · exhibit-a-study-budget.xlsx
… tart Date | Period End Date | Annual Amount | Payment Timing Year 1 | April 7, 2026 | April 6, 2027 | $237,500.00 | Payable within 30 days of period start date Year 2 | Apri …
2026-03-15 · memo-indemnification-analysis.docx
… of its IDE supplement filing with the FDA, which must be submitted by March 15, 2026, to avoid delays to the Cobalt Ridge Health IT-3 enrollment timeline. Both parties have a …
2026-03-15 · memo-ip-publication-rights-analysis.docx
… n terms is critical to support TMRI's IDE supplement filing target of March 15, 2026. II. Background and Parties A. Thornwick Medical Research Institute, Inc. (Sponsor) Thorn …
2026-03-15 · negotiation-comparison-chart.xlsx
… TMRI needs clear ownership for IDE G260012 supplement filing (target March 15, 2026) and future pivotal trial submission. Bayh-Dole Act has limited applicability here — tria …
2026-03-15 · closing-checklist.xlsx
… DE Supplement Filing Materials — preparation for submission to FDA by March 15, 2026 | Christopher Aiken (C&H) / Dr. Elaine K. Sutherland (TMRI) | March 15, 2026 | In Progres …
2026-03-15 · email-indemnification-negotiation-update.eml
… tical to staying on track for the IDE supplement filing deadline of **March 15, 2026** (IDE G260012), and the estimated first patient enrollment of **April 7, 2026**. --- I …
2026-03-15 · email-internal-signing-status-update.eml
… supporting TMRI on the IDE supplement filing with the FDA, targeting March 15, 2026. You'll be working primarily with Marcus Pruitt (General Counsel) and Dr. Elaine Sutherla …
2026-03-15 · email-ip-publication-negotiation-update.eml
… mission pathway — particularly the IDE supplement filing targeted for March 15, 2026 — and preserves future pivotal trial support, while appropriately accommodating the PI's …
2026-03-15 · transmittal-letter-execution-version.docx
… Food and Drug Administration ("FDA"), which is currently targeted for March 15, 2026. Any delay in execution could have downstream consequences for the regulatory timeline, i …
2026-03-15 · clinical-trial-agreement-execution.docx
… as the IDE holder, intends to file an IDE supplement with the FDA by March 15, 2026, referencing this Agreement and adding HUMC as the clinical trial site for the Cadence-3 …
2026-03-02 · memo-indemnification-analysis.docx
… duled for February 21, 2026. The target execution date for the CTA is March 2, 2026. This date is driven by TMRI's need to include the fully executed CTA as part of its IDE …
2026-03-02 · memo-ip-publication-rights-analysis.docx
… scientific conclusions. The target execution date for the CTA remains March 2, 2026. Timely resolution of the IP and publication terms is critical to support TMRI's IDE supp …
2026-03-02 · negotiation-comparison-chart.xlsx
… | G260012 ClinicalTrials.gov ID | NCT06198234 Target Execution Date | March 2, 2026 Sources | HUMC First Redline (February 7, 2026); HUMC Second Redline (February 19, 2026); …
2026-03-02 · closing-checklist.xlsx
… e, Inc. (Sponsor) | TMRI / Marcus D. Pruitt, J.D. (General Counsel) | March 2, 2026 | In Progress | Four original signature copies prepared; CTA dated March 2, 2026; total a …
2026-03-02 · email-indemnification-negotiation-update.eml
… y 17. As a reminder, the **target execution date for the CTA remains March 2, 2026**. Timely resolution of the indemnification provisions is critical to staying on track fo …
2026-03-02 · email-internal-signing-status-update.eml
… niversity Medical Center, Inc. (HUMC) was fully executed as of today, March 2, 2026. The agreement was signed by Dr. Ansel R. Varnham (President & CEO, TMRI) and Dr. Priya A …
2026-03-02 · email-ip-publication-negotiation-update.eml
… *Target Execution Date:** The target execution date remains **Monday, March 2, 2026**. Maintaining this date is important to stay on track for the IDE supplement filing to t …
2026-03-02 · transmittal-letter-execution-version.docx
… terpart signature copies of the Clinical Trial Agreement, dated as of March 2, 2026 (the "Effective Date"). Each counterpart is a complete copy of the agreement and includes …
2026-03-02 · clinical-trial-agreement-execution.docx
… GROVE UNIVERSITY MEDICAL CENTER, INC. ("Institution") Agreement Date: March 2, 2026 ClinicalTrials.gov Identifier: NCT06198234 IDE Number: G260012 TABLE OF CONTENTS Right-cl …
2026-03-02 · exhibit-a-study-budget.xlsx
… Payment Amount | Cumulative Payments to Date | Notes CTA Execution | March 2, 2026 | Upfront Institutional Activation Fee | $300,000.00 | $300,000.00 | Due upon execution o …
2026-03-02 · exhibit-b-protocol-synopsis.docx
… T B Protocol Synopsis Exhibit B to the Clinical Trial Agreement dated March 2, 2026, by and between Thornwick Medical Research Institute, Inc. ("Sponsor") and Hargrove Unive …
2026-02-28 · closing-checklist.xlsx
… arch 2, 2026 | In Progress | Execution version transmitted to PY&C on February 28, 2026; four signature copies enclosed; two fully executed originals to be returned to C&H 3 | A …
2026-02-28 · transmittal-letter-execution-version.docx
… : (617) 884-7000 Facsimile: (617) 884-7001 www.calderwoodharkness.com February 28, 2026 VIA EMAIL AND FedEx Rebecca S. Norcross, Esq. Partner, Life Sciences & Academic Medicine …
2026-02-26 · negotiation-comparison-chart.xlsx
… rwood & Harkness LLP Date Prepared | February 22, 2026 Last Updated | February 26, 2026 Sponsor (Client) | Thornwick Medical Research Institute, Inc. (TMRI) Institution | Hargro …
2026-02-26 · closing-checklist.xlsx
… (Study Budget) and Exhibit B (Protocol Synopsis) finalized | Complete February 26, 2026 | HUMC comments on third draft received | Complete February 28, 2026 | Transmittal of exe …